$AMBS acquired the rights to the Engineered Skin S
Post# of 8672
(Total Views: 131)
Posted On: 06/19/2018 9:51:56 AM
$AMBS acquired the rights to the Engineered Skin Substitute program (ESS), a regenerative medicine-based approach for treating severe burns with full-thickness autologous skin grown in tissue culture that is being pursued by AMBS’ wholly-owned subsidiary Cutanogen Corporation.
https://www.journaltranscript.com/2018/06/is-...-breakout/
https://www.journaltranscript.com/2018/06/is-...-breakout/
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼